Home > Healthcare > Medical Devices > Diagnostic Devices > in vitro toxicology testing market
Get a free sample of In-vitro Toxicology Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of In-vitro Toxicology Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The rise in government funding and initiatives are playing a pivotal role in the industry growth. Multiple governments are actively supporting the development and adoption of alternative testing methods through funding programs and regulatory incentives. These initiatives are aimed at enhancing the accuracy, efficiency, and ethical standards of toxicity testing while reducing reliance on animal models. This rising support will drive innovation in the field and lead to the advancement and widespread adoption of alternative testing methods to ensure safer product development across industries.
For instance, in June 2023, the Tox21 Consortium prioritized substances for detailed toxicological assessment for identifying mechanisms of action and developing predictive models using in-vitro approaches.
Eurofins Scientific, Evotec S.E., Catalent, Inc., Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, SGS Societe Generale de Surveillance SA, and Thermo Fisher Scientific Inc., are some of the major in-vitro toxicology testing companies worldwide.
North America in-vitro toxicology testing industry recorded over USD 857 million in 2023 and is expected to register 7.8% CAGR from 2024-2032 due to growing emphasis on environmental awareness and personalized medicine in the region.
In-vitro toxicology testing industry from the consumables segment is expected to register 7.8% CAGR from 2024-2032 due to continuous advancements and innovations in consumables, facilitating accurate and reliable toxicological assessments.
In-vitro toxicology testing market size was USD 1.8 billion in 2023 and is expected to register 7.7% CAGR from 2024-2032 owing to the rising collaboration and partnerships for driving innovation and growth worldwide.